The DECAF trial shows that drinking one cup of caffeinated coffee a day may actually reduce atrial fibrillation or flutter.

Most patients taking GLP-1 agonists are experiencing positive outcomes for managing type 2 diabetes and obesity. With all the ...

A heart failure polypill was not only associated with better adherence to guideline-directed medicines but also better ...

Artificial intelligence’s momentum is undeniable, and evidence is mounting around its potential to enhance dermatology, but ...

Peak nasal inspiratory flow offers a feasible, noninvasive measure of nasal airflow obstruction in children with cystic ...

The prevalence nearly doubled between 2000 and 2020, with rates among youth nearly eight times higher in those with than ...

Results of a randomized clinical trial published in the JAMA Network Open showed participants who engaged in 6 weeks of daily ...

The EMA’s CHMP has endorsed Ondibta for diabetes and Osqay for osteoporosis, a move that could broaden access to effective, ...

A new study finds Gemini 1.0 delivers the most accurate and readable information on antimicrobial resistance, but experts ...

The drug's recent approval and safety data in women with a history of breast cancer mean there is a new option for women not ...

Resistance exercise, compared with usual care, significantly improves physical function and health-related quality of life in ...

In a world full of noise, introverted doctors can offer calm and focus. Here’s how they harness their gifts to connect with ...